 Parkinson Disease
"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Descriptor ID |
D010300
|
| MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
| Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in UAMS Profiles by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2022 | 6 | 0 | 6 | | 2021 | 8 | 0 | 8 | | 2020 | 4 | 0 | 4 | | 2019 | 12 | 2 | 14 | | 2018 | 7 | 1 | 8 | | 2017 | 8 | 0 | 8 | | 2016 | 14 | 1 | 15 | | 2015 | 12 | 0 | 12 | | 2014 | 6 | 3 | 9 | | 2013 | 8 | 1 | 9 | | 2012 | 7 | 0 | 7 | | 2011 | 5 | 1 | 6 | | 2010 | 3 | 0 | 3 | | 2009 | 5 | 0 | 5 | | 2008 | 5 | 1 | 6 | | 2007 | 1 | 0 | 1 | | 2006 | 1 | 1 | 2 | | 2005 | 2 | 0 | 2 | | 2004 | 0 | 2 | 2 | | 2003 | 4 | 0 | 4 | | 2002 | 2 | 0 | 2 | | 1993 | 1 | 0 | 1 | | 1990 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles over the past ten years.
-
Landes RD, Glover A, Pillai L, Doerhoff S, Virmani T. Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype. PLoS One. 2022; 17(6):e0269227.
-
Pillai L, Glover A, Virmani T. A study of turn bias in people with idiopathic Parkinson's disease. Exp Brain Res. 2022 Jun; 240(6):1673-1685.
-
Secher N, Adelborg K, Szentkúti P, Christiansen CF, Granfeldt A, Henderson VW, Sørensen HT. Evaluation of Neurologic and Psychiatric Outcomes After Hospital Discharge Among Adult Survivors of Cardiac Arrest. JAMA Netw Open. 2022 05 02; 5(5):e2213546.
-
Syeda HB, Glover A, Pillai L, Kemp AS, Spencer H, Lotia M, Larson-Prior LJ, Virmani T. Amplitude setting and dopamine response of finger tapping and gait are related in Parkinson's disease. Sci Rep. 2022 03 09; 12(1):4180.
-
Sundbøll J, Szépligeti SK, Szentkúti P, Adelborg K, Horváth-Puhó E, Pedersen L, Henderson VW, Sørensen HT. Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors. J Am Heart Assoc. 2022 03; 11(5):e022768.
-
Henderson VW. Sleep duration, insomnia, and Parkinson disease. Menopause. 2022 02 07; 29(3):251-252.
-
Pillai L, Shah K, Glover A, Virmani T. Increased foot strike variability during turning in Parkinson's disease patients with freezing of gait. Gait Posture. 2022 02; 92:321-327.
-
Cocoros NM, Svensson E, Szépligeti SK, Vestergaard SV, Szentkúti P, Thomsen RW, Borghammer P, Sørensen HT, Henderson VW. Long-term Risk of Parkinson Disease Following Influenza and Other Infections. JAMA Neurol. 2021 12 01; 78(12):1461-1470.
-
Lu M, Zhao Q, Poston KL, Sullivan EV, Pfefferbaum A, Shahid M, Katz M, Kouhsari LM, Schulman K, Milstein A, Niebles JC, Henderson VW, Fei-Fei L, Pohl KM, Adeli E. Quantifying Parkinson's disease motor severity under uncertainty using MDS-UPDRS videos. Med Image Anal. 2021 10; 73:102179.
-
Moo LR, Martinez E, Padala K, Dunay MA, Scali RR, Chen S, Thielke SM. Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications. Clin Ther. 2021 06; 43(6):942-952.
-
Lench DH, DeVries W, Kearney-Ramos TE, Chesnutt A, Monsch ED, Embry AE, Doolittle JD, Kautz SA, Hanlon CA, Revuelta GJ. Paired inhibitory stimulation and gait training modulates supplemental motor area connectivity in freezing of gait. Parkinsonism Relat Disord. 2021 07; 88:28-33.
-
Olivier GN, Walter CS, Paul SS, Dibble LE, Schaefer SY. How Common Is the Exponential Decay Pattern of Motor Skill Acquisition? A Brief Investigation. Motor Control. 2021 May 13; 25(3):451-461.
-
Baudendistel ST, Schmitt AC, Roemmich RT, Harrison IL, Hass CJ. Levodopa facilitates improvements in gait kinetics at the hip, not the ankle, in individuals with Parkinson's disease. J Biomech. 2021 05 24; 121:110366.
-
Pes GM, Park YM, Sechi GP. Cholesterol Trafficking in the Brain: Are We Overlooking an Important Risk Factor for Parkinson Disease? Neurology. 2021 03 09; 96(10):465-466.
-
Weaver KE, Caldwell DJ, Cronin JA, Kuo CH, Kogan M, Houston B, Sanchez V, Martinez V, Ojemann JG, Rane S, Ko AL. Concurrent Deep Brain Stimulation Reduces the Direct Cortical Stimulation Necessary for Motor Output. Mov Disord. 2020 12; 35(12):2348-2353.
-
Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S, Jeon J, Cha Y, Kim K, Li Q, Henchcliffe C, Kaplitt M, Neff C, Rapalino O, Seo H, Lee IH, Kim J, Kim T, Petsko GA, Ritz J, Cohen BM, Kong SW, Leblanc P, Carter BS, Kim KS. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease. N Engl J Med. 2020 05 14; 382(20):1926-1932.
-
Roper JA, Schmitt AC, Gao H, He Y, Wu S, Schmidt P, Okun MS, Hass CJ, Cubillos F. Coexistent Osteoarthritis and Parkinson's Disease: Data from the Parkinson's Foundation Outcomes Project. J Parkinsons Dis. 2020; 10(4):1601-1610.
-
Glover A, Pillai L, Doerhoff S, Virmani T. Differential Gait Decline in Parkinson's Disease Enhances Discrimination of Gait Freezers from Non-Freezers. J Parkinsons Dis. 2020; 10(4):1657-1673.
-
Grosset DG, Dhall R, Gurevich T, Kassubek J, Poewe WH, Rascol O, Rudzinska M, Cormier J, Sedkov A, Oh C. Inhaled levodopa in Parkinson's disease patients with OFF periods: A randomized 12-month pulmonary safety study. Parkinsonism Relat Disord. 2020 02; 71:4-10.
-
Baudendistel ST, Schmitt AC, Rodriguez AV, McFarland NR, Hass CJ. A turn for the worse: Turning performance in Parkinson's disease and Essential tremor. Clin Biomech (Bristol, Avon). 2019 Dec; 70:245-248.
-
Sharma R, Pillai L, Glover A, Virmani T. Objective impairment of tandem gait in Parkinson's disease patients increases with disease severity. Parkinsonism Relat Disord. 2019 11; 68:33-39.
-
Paul SS, Dibble LE, Olivier GN, Walter C, Duff K, Schaefer SY. Dopamine replacement improves motor learning of an upper extremity task in people with Parkinson disease. Behav Brain Res. 2020 01 13; 377:112213.
-
Gupta HV, Lyons KE, Pahwa R. Old Drugs, New Delivery Systems in Parkinson's Disease. Drugs Aging. 2019 09; 36(9):807-821.
-
Schmitt AC, Daniels JN, Baudendistel ST, Okun MS, Hass CJ. The Primary Gait Screen in Parkinson's disease: Comparison to standardized measures. Gait Posture. 2019 09; 73:71-73.
-
Garcia-Rill E, Saper CB, Rye DB, Kofler M, Nonnekes J, Lozano A, Valls-Solé J, Hallett M. Focus on the pedunculopontine nucleus. Consensus review from the May 2018 brainstem society meeting in Washington, DC, USA. Clin Neurophysiol. 2019 06; 130(6):925-940.
-
Garcia-Rill E. Neuroepigenetics of arousal: Gamma oscillations in the pedunculopontine nucleus. J Neurosci Res. 2019 12; 97(12):1515-1520.
-
Shahid M, Kim J, Leaver K, Hendershott T, Zhu D, Cholerton B, Henderson VW, Tian L, Poston KL. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE e4 allele. Neurobiol Dis. 2019 07; 127:278-286.
-
Deng X, Xiao B, Allen JC, Ng E, Foo JN, Lo YL, Tan LCS, Tan EK. Parkinson's disease GWAS-linked Park16 carriers show greater motor progression. J Med Genet. 2019 11; 56(11):765-768.
-
Schoellmann A, Scholten M, Wasserka B, Govindan RB, Krüger R, Gharabaghi A, Plewnia C, Weiss D. Anodal tDCS modulates cortical activity and synchronization in Parkinson's disease depending on motor processing. Neuroimage Clin. 2019; 22:101689.
-
Santiago A, Langston JW, Gandhy R, Dhall R, Brillman S, Rees L, Barlow C. Qualitative Evaluation of the Personal KinetiGraphTM Movement Recording System in a Parkinson's Clinic. J Parkinsons Dis. 2019; 9(1):207-219.
-
Ording AG, Veres K, Horváth-Puhó E, Glymour MM, Rørth M, Henderson VW, Sørensen HT. Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study. J Alzheimers Dis. 2019; 72(4):1269-1277.
-
Olivier GN, Paul SS, Lohse KR, Walter CS, Schaefer SY, Dibble LE. Predicting Motor Sequence Learning in People With Parkinson Disease. J Neurol Phys Ther. 2019 01; 43(1):33-41.
-
Iadanza MG, Jackson MP, Hewitt EW, Ranson NA, Radford SE. A new era for understanding amyloid structures and disease. Nat Rev Mol Cell Biol. 2018 12; 19(12):755-773.
-
Paul SS, Schaefer SY, Olivier GN, Walter CS, Lohse KR, Dibble LE. Dopamine Replacement Medication Does Not Influence Implicit Learning of a Stepping Task in People With Parkinson's Disease. Neurorehabil Neural Repair. 2018 12; 32(12):1031-1042.
-
Virmani T, Pillai L, Glover A, Doerhoff SM, Williams DK, Garcia-Rill E, Larson-Prior L. Impaired step-length setting prior to turning in Parkinson's disease patients with freezing of gait. Mov Disord. 2018 11; 33(11):1823-1825.
-
Shah J, Pillai L, Williams DK, Doerhoff SM, Larson-Prior L, Garcia-Rill E, Virmani T. Increased foot strike variability in Parkinson's disease patients with freezing of gait. Parkinsonism Relat Disord. 2018 08; 53:58-63.
-
Chen T, Mirzadeh Z, Chapple KM, Lambert M, Shill HA, Moguel-Cobos G, Tröster AI, Dhall R, Ponce FA. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2018 03 16; 130(1):109-120.
-
Doherty CPA, Young LM, Karamanos TK, Smith HI, Jackson MP, Radford SE, Brockwell DJ. A peptide-display protein scaffold to facilitate single molecule force studies of aggregation-prone peptides. Protein Sci. 2018 07; 27(7):1205-1217.
-
Garcia-Rill E, Mahaffey S, Hyde JR, Urbano FJ. Bottom-up gamma maintenance in various disorders. Neurobiol Dis. 2019 08; 128:31-39.
-
Xiao B, Deng X, Ng EY, Allen JC, Lim SY, Ahmad-Annuar A, Tan EK. Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease. JAMA Neurol. 2018 01 01; 75(1):127-128.
-
Svensson E, Henderson VW, Szépligeti S, Stokholm MG, Klug TE, Sørensen HT, Borghammer P. Tonsillectomy and risk of Parkinson's disease: A danish nationwide population-based cohort study. Mov Disord. 2018 02; 33(2):321-324.
-
Lieberman A, Deep A, Shi J, Dhall R, Shafer S, Moguel-Cobos G, Dhillon R, Frames CW, McCauley M. Downward finger displacement distinguishes Parkinson disease dementia from Alzheimer disease. Int J Neurosci. 2018 Feb; 128(2):151-154.
-
Leehey M, Luo S, Sharma S, Wills AA, Bainbridge JL, Wong PS, Simon DK, Schneider J, Zhang Y, Pérez A, Dhall R, Christine CW, Singer C, Cambi F, Boyd JT. Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores. Neurology. 2017 Oct 24; 89(17):1789-1794.
-
Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017 Sep 12; 89(11):1152-1161.
-
Patel S, Garcia X, Mohammad ME, Yu XX, Vlastaris K, O'Donnell K, Sutton K, Fernandez HH. Dopamine agonist withdrawal syndrome (DAWS) in a tertiary Parkinson disease treatment center. J Neurol Sci. 2017 Aug 15; 379:308-311.
-
Ho AL, Ali R, Connolly ID, Henderson JM, Dhall R, Stein SC, Halpern CH. Awake versus asleep deep brain stimulation for Parkinson's disease: a critical comparison and meta-analysis. J Neurol Neurosurg Psychiatry. 2018 07; 89(7):687-691.
-
Heldman DA, Urrea-Mendoza E, Lovera LC, Schmerler DA, Garcia X, Mohammad ME, McFarlane MCU, Giuffrida JP, Espay AJ, Fernandez HH. App-Based Bradykinesia Tasks for Clinic and Home Assessment in Parkinson's Disease: Reliability and Responsiveness. J Parkinsons Dis. 2017; 7(4):741-747.
-
Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine CW, Dhall R, Umeh CC, Boyd JT, Stover N, Leehey M, Zweig RM, Nicholas AP, Bodis-Wollner I, Willis A, Kieburtz K, Tilley BC. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. J Parkinsons Dis. 2017; 7(1):117-127.
-
Hamani C, Lozano AM, Mazzone PA, Moro E, Hutchison W, Silburn PA, Zrinzo L, Alam M, Goetz L, Pereira E, Rughani A, Thevathasan W, Aziz T, Bloem BR, Brown P, Chabardes S, Coyne T, Foote K, Garcia-Rill E, Hirsch EC, Okun MS, Krauss JK. Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Techniques, Side Effects, and Postoperative Imaging. Stereotact Funct Neurosurg. 2016; 94(5):307-319.
-
Hamani C, Aziz T, Bloem BR, Brown P, Chabardes S, Coyne T, Foote K, Garcia-Rill E, Hirsch EC, Lozano AM, Mazzone PA, Okun MS, Hutchison W, Silburn P, Zrinzo L, Alam M, Goetz L, Pereira E, Rughani A, Thevathasan W, Moro E, Krauss JK. Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Anatomy and Terminology. Stereotact Funct Neurosurg. 2016; 94(5):298-306.
-
Svensson E, Horváth-Puhó E, Stokholm MG, Sørensen HT, Henderson VW, Borghammer P. Appendectomy and risk of Parkinson's disease: A nationwide cohort study with more than 10 years of follow-up. Mov Disord. 2016 12; 31(12):1918-1922.
-
Wadhwa V, Belzberg AJ, Carrino JA, Chhabra A. Lumbar Radiculopathy - Incremental Value of Magnetic Resonance Neurography over Non-Contributory Magnetic Resonance Imaging. Ann Acad Med Singap. 2016 Aug; 45(8):376-8.
-
Nada EM, Rajan S, Grandhe R, Deogaonkar M, Zimmerman NM, Ebrahim Z, Avitsian R. Intraoperative Hypotension During Second Stage of Deep Brain Stimulator Placement: Same Day versus Different Day Procedures. World Neurosurg. 2016 Nov; 95:40-45.
-
Sarkar S, Raymick J, Imam S. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives. Int J Mol Sci. 2016 Jun 08; 17(6).
-
Svensson E, Henderson VW, Borghammer P, Horváth-Puhó E, Sørensen HT. Constipation and risk of Parkinson's disease: A Danish population-based cohort study. Parkinsonism Relat Disord. 2016 07; 28:18-22.
-
Robakis D, Cortes E, Clark LN, Vonsattel JP, Virmani T, Alcalay RN, Crary JF, Levy OA. The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease. J Neural Transm (Vienna). 2016 06; 123(6):583-8.
-
Dhall R, Kreitzman DL. Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety. Neurology. 2016 Apr 05; 86(14 Suppl 1):S13-24.
-
Wang X, Li N, Xiong N, You Q, Li J, Yu J, Qing H, Wang T, Cordell HJ, Isacson O, Vance JM, Martin ER, Zhao Y, Cohen BM, Buttner EA, Lin Z. Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's Disease. Mol Neurobiol. 2017 05; 54(4):2878-2888.
-
Scholten M, Govindan RB, Braun C, Bloem BR, Plewnia C, Krüger R, Gharabaghi A, Weiss D. Cortical correlates of susceptibility to upper limb freezing in Parkinson's disease. Clin Neurophysiol. 2016 06; 127(6):2386-93.
-
Jacob S, Ly H, Villenueva RJ, Gupta HV. Acute dystonic reaction in a patient with Parkinson's disease after diphenhydramine withdrawal. Acta Neurol Belg. 2017 03; 117(1):345-346.
-
Lotia M, Jankovic J. New and emerging medical therapies in Parkinson's disease. Expert Opin Pharmacother. 2016; 17(7):895-909.
-
Dorsey ER, Achey MA, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Ziman N, Aldred J, Carter J, Jimenez-Shahed J, Hunter C, Spindler M, Mari Z, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Bull MT, Mejia NI, Bwala G, Nance M, Shih L, Anderson L, Singer C, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Cooper J, Webb S, Dhall R, Hassan A, Weis D, DeMello S, Riggare SS, Wicks P, Smith J, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W. National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and Barriers. Telemed J E Health. 2016 07; 22(7):590-8.
-
Gupta R, Kim C, Agarwal N, Lieber BA, Monaco EA. In Reply to the Letter to the Editor, "Influence of Parkinsonism on Hitler's Decision-Making". World Neurosurg. 2016 Feb; 86:5.
-
Mirzadeh Z, Chapple K, Lambert M, Evidente VG, Mahant P, Ospina MC, Samanta J, Moguel-Cobos G, Salins N, Lieberman A, Tröster AI, Dhall R, Ponce FA. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus. J Neurosurg. 2016 Apr; 124(4):902-7.
-
Oosterveld LP, Allen JC, Ng EY, Seah SH, Tay KY, Au WL, Tan EK, Tan LC. Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants. Neurology. 2015 Sep 22; 85(12):1039-42.
-
Virmani T, Moskowitz CB, Vonsattel JP, Fahn S. Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson's disease. Mov Disord. 2015 Dec; 30(14):1874-84.
-
Augustine EF, Pérez A, Dhall R, Umeh CC, Videnovic A, Cambi F, Wills AM, Elm JJ, Zweig RM, Shulman LM, Nance MA, Bainbridge J, Suchowersky O. Sex Differences in Clinical Features of Early, Treated Parkinson's Disease. PLoS One. 2015; 10(7):e0133002.
-
Lawand NB, Saadé NE, El-Agnaf OM, Safieh-Garabedian B. Targeting a-synuclein as a therapeutic strategy for Parkinson's disease. Expert Opin Ther Targets. 2015; 19(10):1351-60.
-
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. Lancet Neurol. 2015 Aug; 14(8):795-803.
-
Gupta R, Kim C, Agarwal N, Lieber B, Monaco EA. Understanding the Influence of Parkinson Disease on Adolf Hitler's Decision-Making during World War II. World Neurosurg. 2015 Nov; 84(5):1447-52.
-
Lieber B, Taylor BE, Appelboom G, McKhann G, Connolly ES. Motion Sensors to Assess and Monitor Medical and Surgical Management of Parkinson Disease. World Neurosurg. 2015 Aug; 84(2):561-6.
-
Scholten M, Klotz R, Plewnia C, Wächter T, Mielke C, Bloem BR, Braun C, Ziemann U, Govindan RB, Gharabaghi A, Krüger R, Weiss D. Neuromuscular correlates of subthalamic stimulation and upper limb freezing in Parkinson's disease. Clin Neurophysiol. 2016 Jan; 127(1):610-620.
-
Zawada WM, Mrak RE, Biedermann J, Palmer QD, Gentleman SM, Aboud O, Griffin WS. Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation. Acta Neuropathol Commun. 2015 Feb 03; 3:9.
-
Weiss D, Klotz R, Govindan RB, Scholten M, Naros G, Ramos-Murguialday A, Bunjes F, Meisner C, Plewnia C, Krüger R, Gharabaghi A. Subthalamic stimulation modulates cortical motor network activity and synchronization in Parkinson's disease. Brain. 2015 Mar; 138(Pt 3):679-93.
-
Tramontana MG, Molinari AL, Konrad PE, Davis TL, Wylie SA, Neimat JS, May AT, Phibbs FT, Hedera P, Gill CE, Salomon RM, Wang L, Song Y, Charles D. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial. J Parkinsons Dis. 2015; 5(1):151-63.
-
Oosterveld LP, Allen JC, Reinoso G, Seah SH, Tay KY, Au WL, Tan LC. Prognostic factors for early mortality in Parkinson's disease. Parkinsonism Relat Disord. 2015 Mar; 21(3):226-30.
-
Fang JY, Pérez A, Christine CW, Leehey M, Aminoff MJ, Boyd JT, Morgan JC, Dhall R, Nicholas AP, Bodis-Wollner I, Zweig RM, Goudreau JL. Parkinson's disease severity and use of dopaminergic medications. Parkinsonism Relat Disord. 2015 Mar; 21(3):297-9.
-
Umeh CC, Pérez A, Augustine EF, Dhall R, Dewey RB, Mari Z, Simon DK, Wills AM, Christine CW, Schneider JS, Suchowersky O. No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial. PLoS One. 2014; 9(12):e112287.
-
Rajan S, Deogaonkar M, Kaw R, Nada EM, Hernandez AV, Ebrahim Z, Avitsian R. Factors predicting incremental administration of antihypertensive boluses during deep brain stimulator placement for Parkinson's disease. J Clin Neurosci. 2014 Oct; 21(10):1790-5.
-
Kuang XL, Liu F, Chen H, Li Y, Liu Y, Xiao J, Shan G, Li M, Snider BJ, Qu J, Barger SW, Wu S. Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease. J Neurosci Res. 2014 Oct; 92(10):1319-29.
-
Charles D, Konrad PE, Neimat JS, Molinari AL, Tramontana MG, Finder SG, Gill CE, Bliton MJ, Kao C, Phibbs FT, Hedera P, Salomon RM, Cannard KR, Wang L, Song Y, Davis TL. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord. 2014 Jul; 20(7):731-7.
-
Telford R, Vattoth S. MR anatomy of deep brain nuclei with special reference to specific diseases and deep brain stimulation localization. Neuroradiol J. 2014 Feb; 27(1):29-43.
-
Strathearn KE, Yousef GG, Grace MH, Roy SL, Tambe MA, Ferruzzi MG, Wu QL, Simon JE, Lila MA, Rochet JC. Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson?s disease. Brain Res. 2014 Mar 25; 1555:60-77.
-
Zhang L, Balan G, Barreiro G, Boscoe BP, Chenard LK, Cianfrogna J, Claffey MM, Chen L, Coffman KJ, Drozda SE, Dunetz JR, Fonseca KR, Galatsis P, Grimwood S, Lazzaro JT, Mancuso JY, Miller EL, Reese MR, Rogers BN, Sakurada I, Skaddan M, Smith DL, Stepan AF, Trapa P, Tuttle JB, Verhoest PR, Walker DP, Wright AS, Zaleska MM, Zasadny K, Shaffer CL. Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator. J Med Chem. 2014 Feb 13; 57(3):861-77.
-
Lieberman A, Dhall R, Salins N, Sadreddin A, Moguel-Cobos G, Karis J, Krishnamurthi N. Finger displacement in Parkinson disease: up? down? sideways? Int J Neurosci. 2014 May; 124(5):339-43.
-
Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 2014 Jan 14; 82(2):163-71.
-
Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A, Dhall R, Ballard C. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014 Feb 08; 383(9916):533-40.
-
Virmani T, Thenganatt MA, Goldman JS, Kubisch C, Greene PE, Alcalay RN. Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia. Parkinsonism Relat Disord. 2014 Feb; 20(2):245-7.
-
Lieberman A, Dhall R, Dhanani S, Salins N, Sadreddin A, Moguel-Cobos G, Pan D, Santiago A, Prigatano G, Krishnamurthi N, Troster A. Distinguishing the tremor of Parkinson's disease from essential tremor: finger displacement. Int J Neurosci. 2014 Mar; 124(3):175-80.
-
Imam SZ, Trickler W, Kimura S, Binienda ZK, Paule MG, Slikker W, Li S, Clark RA, Ali SF. Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model. PLoS One. 2013; 8(5):e65129.
-
Yong MH, Allen JC, Prakash KM, Tan EK. Differentiating non-motor symptoms in Parkinson's disease from controls and hemifacial spasm. PLoS One. 2013; 8(2):e49596.
-
Shabbir F, Patel A, Mattison C, Bose S, Krishnamohan R, Sweeney E, Sandhu S, Nel W, Rais A, Sandhu R, Ngu N, Sharma S. Effect of diet on serotonergic neurotransmission in depression. Neurochem Int. 2013 Feb; 62(3):324-9.
-
Biju KC, Santacruz RA, Chen C, Zhou Q, Yao J, Rohrabaugh SL, Clark RA, Roberts JL, Phillips KA, Imam SZ, Li S. Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Neurosci Lett. 2013 Feb 22; 535:24-9.
-
Willis AW, Schootman M, Kung N, Racette BA. Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States. Parkinsonism Relat Disord. 2013 Feb; 19(2):202-6.
-
Willis AW, Schootman M, Tran R, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Neurologist-associated reduction in PD-related hospitalizations and health care expenditures. Neurology. 2012 Oct 23; 79(17):1774-80.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|